Puerto Rico
|
|
66-0555678
|
(State or other jurisdiction of incorporation or organization)
|
|
(I.R.S. Employer Identification No.)
|
1441 F.D. Roosevelt Avenue
|
|
|
San Juan, Puerto Rico
|
|
00920
|
(Address of principal executive offices)
|
|
(Zip code)
|
(787) 749-4949
|
(Registrant’s telephone number, including area code)
|
Not applicable
|
(Former name, former address and former fiscal year, if changed since last report)
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange on which registered
|
Common Stock Class B, $1.00 par value
|
GTS
|
New York Stock Exchange (NYSE)
|
Large accelerated filer ☑
|
Accelerated filer ☐
|
Non-accelerated filer ☐
|
Smaller reporting company ☐
|
Emerging growth company ☐
|
Title of each class
|
Outstanding at June 30, 2020
|
Common Stock Class B, $1.00 par value
|
23,437,565
|
3
|
|
34
|
|
34
|
|
34
|
|
35
|
|
38
|
|
38
|
|
39
|
|
41
|
|
44
|
|
45
|
|
46
|
|
48
|
|
49
|
|
49
|
|
49
|
|
49
|
|
51
|
|
51
|
|
51
|
|
51
|
|
52
|
|
53
|
|
June 30,
2020
|
December 31,
2019
|
||||||
Assets
|
||||||||
Investments and cash:
|
||||||||
Fixed maturities available for sale, at fair value
|
$
|
1,292,751
|
$
|
1,242,883
|
||||
Fixed maturities held to maturity, at amortized cost
|
1,860
|
1,860
|
||||||
Equity investments, at fair value
|
344,604
|
287,525
|
||||||
Other invested assets, at net asset value
|
105,525
|
100,508
|
||||||
Policy loans
|
10,958
|
10,861
|
||||||
Cash and cash equivalents
|
141,071
|
109,837
|
||||||
Total investments and cash
|
1,896,769
|
1,753,474
|
||||||
Premiums and other receivables, net
|
547,209
|
567,692
|
||||||
Deferred policy acquisition costs and value of business acquired
|
238,636
|
234,885
|
||||||
Property and equipment, net
|
126,685
|
88,588
|
||||||
Deferred tax asset
|
76,010
|
77,294
|
||||||
Goodwill
|
28,614
|
28,599
|
||||||
Other assets
|
107,507
|
68,294
|
||||||
Total assets
|
$
|
3,021,430
|
$
|
2,818,826
|
||||
Liabilities and Stockholders’ Equity
|
||||||||
Claim liabilities
|
$
|
725,214
|
$
|
709,258
|
||||
Liability for future policy benefits
|
396,205
|
386,017
|
||||||
Unearned premiums
|
89,456
|
93,301
|
||||||
Policyholder deposits
|
200,499
|
189,120
|
||||||
Liability to Federal Employees’ Health Benefits and Federal Employees’ Programs
|
59,184
|
47,781
|
||||||
Accounts payable and accrued liabilities
|
456,607
|
325,761
|
||||||
Deferred tax liability
|
10,999
|
10,257
|
||||||
Short-term borrowings
|
15,000
|
54,000
|
||||||
Long-term borrowings
|
54,940
|
25,694
|
||||||
Liability for pension benefits
|
33,791
|
34,465
|
||||||
Total liabilities
|
2,041,895
|
1,875,654
|
||||||
Stockholders’ equity:
|
||||||||
Triple-S Management Corporation stockholders’ equity
|
||||||||
Common stock Class B, $1 par value. Authorized 100,000,000 shares; issued and outstanding 23,437,565 and 23,799,633 shares at June 30, 2020 and December 31, 2019, respectively
|
23,438
|
23,800
|
||||||
Additional paid-in capital
|
52,372
|
60,504
|
||||||
Retained earnings
|
847,486
|
830,198
|
||||||
Accumulated other comprehensive income
|
56,949
|
29,363
|
||||||
Total Triple-S Management Corporation stockholders’ equity
|
980,245
|
943,865
|
||||||
Non-controlling interest in consolidated subsidiary
|
(710
|
)
|
(693
|
)
|
||||
Total stockholders’ equity
|
979,535
|
943,172
|
||||||
Total liabilities and stockholders’ equity
|
$
|
3,021,430
|
$
|
2,818,826
|
|
Three months ended
June 30,
|
Six months ended
June 30,
|
||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
||||||||||||
Revenues:
|
||||||||||||||||
Premiums earned, net
|
$
|
858,535
|
$
|
859,493
|
$
|
1,734,432
|
$
|
1,627,495
|
||||||||
Administrative service fees
|
2,809
|
2,456
|
5,003
|
5,088
|
||||||||||||
Net investment income
|
13,815
|
15,062
|
28,126
|
30,438
|
||||||||||||
Other operating revenues
|
303
|
1,591
|
4,342
|
3,168
|
||||||||||||
Total operating revenues
|
875,462
|
878,602
|
1,771,903
|
1,666,189
|
||||||||||||
Net realized investment (losses) gains
|
(221
|
)
|
2,364
|
(687
|
)
|
3,679
|
||||||||||
Net unrealized investment gains (losses) on equity investments
|
28,338
|
3,323
|
(28,468
|
)
|
22,992
|
|||||||||||
Other income, net
|
801
|
1,705
|
4,406
|
2,874
|
||||||||||||
Total revenues
|
904,380
|
885,994
|
1,747,154
|
1,695,734
|
||||||||||||
Benefits and expenses:
|
||||||||||||||||
Claims incurred
|
653,087
|
706,304
|
1,367,609
|
1,329,494
|
||||||||||||
Operating expenses
|
178,659
|
134,084
|
340,860
|
266,747
|
||||||||||||
Total operating costs
|
831,746
|
840,388
|
1,708,469
|
1,596,241
|
||||||||||||
Interest expense
|
1,864
|
1,831
|
3,717
|
3,619
|
||||||||||||
Total benefits and expenses
|
833,610
|
842,219
|
1,712,186
|
1,599,860
|
||||||||||||
Income before taxes
|
70,770
|
43,775
|
34,968
|
95,874
|
||||||||||||
Income tax expense
|
27,181
|
12,849
|
17,531
|
30,165
|
||||||||||||
Net income
|
43,589
|
30,926
|
17,437
|
65,709
|
||||||||||||
Net loss attributable to non-controlling interest
|
(10
|
)
|
(5
|
)
|
(17
|
)
|
(8
|
)
|
||||||||
Net income attributable to Triple-S Management Corporation
|
$
|
43,599
|
$
|
30,931
|
$
|
17,454
|
$
|
65,717
|
||||||||
Earnings per share attributable to Triple-S Management Corporation
|
||||||||||||||||
Basic net income per share
|
$
|
1.88
|
$
|
1.35
|
$
|
0.75
|
$
|
2.88
|
||||||||
Diluted net income per share
|
$
|
1.87
|
$
|
1.35
|
$
|
0.75
|
$
|
2.87
|
|
Three months ended
June 30,
|
Six months ended
June 30,
|
||
|
2020
|
2019
|
2020
|
2019
|
Net income
|
$43,589
|
$30,926
|
$17,437
|
$65,709
|
Other comprehensive income, net of tax:
|
|
|
||
Net unrealized change in fair value of available for sale securities, net of taxes
|
11,401
|
14,929
|
27,280
|
28,370
|
Defined benefit pension plan:
|
|
|
||
Actuarial loss, net
|
153
|
56
|
306
|
112
|
Total other comprehensive income, net of tax
|
11,554
|
14,985
|
27,586
|
28,482
|
Comprehensive income
|
55,143
|
45,911
|
45,023
|
94,191
|
Comprehensive loss attributable to non-controlling interest
|
(10)
|
(5)
|
(17)
|
(8)
|
Comprehensive income attributable to Triple-S Management Corporation
|
$55,153
|
$45,916
|
$45,040
|
$94,199
|
|
Class A
Common
Stock
|
Class B
Common
Stock
|
Additional
Paid-in
Capital
|
Retained
Earnings
|
Accumulated
Other
Comprehensive
Income
|
Triple-S
Management
Corporation
Stockholders’
Equity
|
Non-controlling
Interest in
Consolidated
Subsidiary
|
Total
Stockholders’
Equity
|
||||||||||||||||||||||||
Balance, December 31, 2019
|
$
|
-
|
$
|
23,800
|
$
|
60,504
|
$
|
830,198
|
$
|
29,363
|
$
|
943,865
|
$
|
(693
|
)
|
$
|
943,172
|
|||||||||||||||
Share-based compensation
|
-
|
590
|
1,769
|
-
|
-
|
2,359
|
-
|
2,359
|
||||||||||||||||||||||||
Repurchase and retirement of common stock
|
-
|
(584
|
)
|
(8,511
|
)
|
-
|
-
|
(9,095
|
)
|
-
|
(9,095
|
)
|
||||||||||||||||||||
Comprehensive (loss) income
|
-
|
-
|
-
|
(26,145
|
)
|
16,032
|
(10,113
|
)
|
(7
|
)
|
(10,120
|
)
|
||||||||||||||||||||
Cummulative effect adjustment due to implementation of ASU 2016-13
|
-
|
-
|
-
|
(166
|
)
|
-
|
(166
|
)
|
-
|
(166
|
)
|
|||||||||||||||||||||
Balance, March 31, 2020
|
$
|
-
|
$
|
23,806
|
$
|
53,762
|
$
|
803,887
|
$
|
45,395
|
$
|
926,850
|
$
|
(700
|
)
|
$
|
926,150
|
|||||||||||||||
Share-based compensation
|
-
|
7
|
4,228
|
-
|
-
|
4,235
|
-
|
4,235
|
||||||||||||||||||||||||
Repurchase and retirement of common stock
|
-
|
(375
|
)
|
(5,618
|
)
|
-
|
-
|
(5,993
|
)
|
-
|
(5,993
|
)
|
||||||||||||||||||||
Comprehensive income (loss)
|
-
|
-
|
-
|
43,599
|
11,554
|
55,153
|
(10
|
)
|
55,143
|
|||||||||||||||||||||||
Balance, June 30, 2020
|
$
|
-
|
$
|
23,438
|
$
|
52,372
|
$
|
847,486
|
$
|
56,949
|
$
|
980,245
|
$
|
(710
|
)
|
$
|
979,535
|
|||||||||||||||
Balance, December 31, 2018
|
$
|
951
|
$
|
21,980
|
$
|
34,021
|
$
|
761,970
|
$
|
3,062
|
$
|
821,984
|
$
|
(676
|
)
|
$
|
821,308
|
|||||||||||||||
Share-based compensation
|
-
|
177
|
1,409
|
-
|
-
|
1,586
|
-
|
1,586
|
||||||||||||||||||||||||
Repurchase and retirement of common stock
|
-
|
(1
|
)
|
(15
|
)
|
-
|
-
|
(16
|
)
|
-
|
(16
|
)
|
||||||||||||||||||||
Comprehensive income (loss)
|
-
|
-
|
-
|
34,786
|
13,497
|
48,283
|
(3
|
)
|
48,280
|
|||||||||||||||||||||||
Balance, March 31, 2019
|
$
|
951
|
$
|
22,156
|
$
|
35,415
|
$
|
796,756
|
$
|
16,559
|
$
|
871,837
|
$
|
(679
|
)
|
$
|
871,158
|
|||||||||||||||
Share-based compensation
|
-
|
44
|
4,276
|
-
|
-
|
4,320
|
-
|
4,320
|
||||||||||||||||||||||||
Comprehensive income (loss)
|
-
|
-
|
-
|
30,931
|
14,985
|
45,916
|
(5
|
)
|
45,911
|
|||||||||||||||||||||||
Balance, June 30, 2019
|
$
|
951
|
$
|
22,200
|
$
|
39,691
|
$
|
827,687
|
$
|
31,544
|
$
|
922,073
|
$
|
(684
|
)
|
$
|
921,389
|
|
Six months ended
June 30,
|
|||||||
|
2020
|
2019
|
||||||
Cash flows from operating activities:
|
||||||||
Net income
|
$
|
17,437
|
$
|
65,709
|
||||
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
Depreciation and amortization
|
7,744
|
7,045
|
||||||
Net amortization of investments
|
1,270
|
847
|
||||||
Additions to the allowance for doubtful receivables
|
5,658
|
246
|
||||||
Deferred tax (benefit) expense
|
(4,976
|
)
|
16,592
|
|||||
Net realized investment losses (gains) on sale of securities
|
687
|
(3,679
|
)
|
|||||
Net unrealized losses (gains) on equity investments
|
28,468
|
(22,992
|
)
|
|||||
Interest credited to policyholder deposits
|
3,160
|
2,811
|
||||||
Share-based compensation
|
6,594
|
5,907
|
||||||
Loss on disposition of property and equipment
|
154
|
-
|
||||||
Decrease (increase) in assets:
|
||||||||
Premium and other receivables, net
|
22,359
|
18,674
|
||||||
Deferred policy acquisition costs and value of business acquired
|
(5,588
|
)
|
(12,475
|
)
|
||||
Deferred taxes
|
(91
|
)
|
69
|
|||||
Other assets
|
(35,348
|
)
|
(4,767
|
)
|
||||
Increase (decrease) in liabilities:
|
||||||||
Claim liabilities
|
15,956
|
(71,362
|
)
|
|||||
Liability for future policy benefits
|
10,188
|
13,164
|
||||||
Unearned premiums
|
(3,845
|
)
|
(521
|
)
|
||||
Liability to Federal Employees’ Health Benefits and Federal Employees’ Programs
|
11,403
|
4,239
|
||||||
Accounts payable and accrued liabilities
|
89,052
|
6,798
|
||||||
Net cash provided by operating activities
|
170,282
|
26,305
|
|
Six months ended
June 30,
|
|||||||
|
2020
|
2019
|
||||||
|
||||||||
Cash flows from investing activities:
|
||||||||
Proceeds from investments sold or matured:
|
||||||||
Securities available for sale:
|
||||||||
Fixed maturities sold
|
$
|
66,316
|
$
|
315,495
|
||||
Fixed maturities matured/called
|
18,752
|
14,420
|
||||||
Securities held to maturity:
|
||||||||
Fixed maturities matured/called
|
339
|
1,178
|
||||||
Equity investments sold
|
72,775
|
70,054
|
||||||
Other invested assets sold
|
11,814
|
2,096
|
||||||
Acquisition of investments:
|
||||||||
Securities available for sale:
|
||||||||
Fixed maturities
|
(91,930
|
)
|
(291,533
|
)
|
||||
Securities held to maturity:
|
||||||||
Fixed maturities
|
(340
|
)
|
(539
|
)
|
||||
Equity investments
|
(160,104
|
)
|
(67,560
|
)
|
||||
Other invested assets
|
(20,799
|
)
|
(15,424
|
)
|
||||
Increase in other investments
|
(2,400
|
)
|
(2,692
|
)
|
||||
Net change in policy loans
|
(97
|
)
|
(771
|
)
|
||||
Net capital expenditures
|
(45,927
|
)
|
(10,659
|
)
|
||||
Capital contribution on equity method investees
|
(4,933
|
)
|
-
|
|||||
Net cash (used in) provided by investing activities
|
(156,534
|
)
|
14,065
|
|||||
Cash flows from financing activities:
|
||||||||
Change in outstanding checks in excess of bank balances
|
34,024
|
13,189
|
||||||
Repayments of short-term borrowings
|
(39,000
|
)
|
-
|
|||||
Proceeds from long-term borrowings
|
30,841
|
-
|
||||||
Repayments of long-term borrowings
|
(1,618
|
)
|
(1,613
|
)
|
||||
Repurchase and retirement of common stock
|
(14,982
|
)
|
(1
|
)
|
||||
Proceeds from policyholder deposits
|
16,421
|
8,204
|
||||||
Surrenders of policyholder deposits
|
(8,200
|
)
|
(11,421
|
)
|
||||
Net cash provided by financing activities
|
17,486
|
8,358
|
||||||
Net increase in cash and cash equivalents
|
31,234
|
48,728
|
||||||
Cash and cash equivalents:
|
||||||||
Beginning of period
|
109,837
|
117,544
|
||||||
End of period
|
$
|
141,071
|
$
|
166,272
|
(1) |
Basis of Presentation
|
(2) |
Significant Accounting Policies
|
(3) |
Investment in Securities
|
|
June 30, 2020
|
|||||||||||||||
|
Amortized
cost
|
Gross
unrealized
gains
|
Gross
unrealized
losses
|
Estimated
fair value
|
||||||||||||
Fixed maturities available for sale
|
||||||||||||||||
Obligations of government- sponsored enterprises
|
$
|
17,198
|
$
|
834
|
$
|
-
|
$
|
18,032
|
||||||||
U.S. Treasury securities and obligations of U.S. government instrumentalities
|
102,649
|
9,318
|
-
|
111,967
|
||||||||||||
Municipal securities
|
592,541
|
51,941
|
-
|
644,482
|
||||||||||||
Corporate bonds
|
195,227
|
31,534
|
-
|
226,761
|
||||||||||||
Residential mortgage-backed securities
|
267,075
|
15,965
|
(263
|
)
|
282,777
|
|||||||||||
Collateralized mortgage obligations
|
7,983
|
749
|
-
|
8,732
|
||||||||||||
Total fixed maturities available for sale
|
$
|
1,182,673
|
$
|
110,341
|
$
|
(263
|
)
|
$
|
1,292,751
|
|
December 31, 2019
|
|||||||||||||||
|
Amortized
cost
|
Gross
Unrealized
gains
|
Gross
Unrealized
losses
|
Estimated
fair value
|
||||||||||||
Fixed maturities available for sale
|
||||||||||||||||
Obligations of government- sponsored enterprises
|
$
|
17,209
|
$
|
477
|
$
|
-
|
$
|
17,686
|
||||||||
U.S. Treasury securities and obligations of U.S. government instrumentalities
|
102,230
|
4,779
|
-
|
107,009
|
||||||||||||
Municipal securities
|
595,051
|
34,735
|
(22
|
)
|
629,764
|
|||||||||||
Corporate bonds
|
187,096
|
21,721
|
(74
|
)
|
208,743
|
|||||||||||
Residential mortgage-backed securities
|
262,783
|
8,073
|
(320
|
)
|
270,536
|
|||||||||||
Collateralized mortgage obligations
|
8,674
|
471
|
-
|
9,145
|
||||||||||||
Total fixed maturities available for sale
|
$
|
1,173,043
|
$
|
70,256
|
$
|
(416
|
)
|
$
|
1,242,883
|
|
June 30, 2020
|
|||||||||||||||
|
Amortized
cost
|
Gross
unrealized
gains
|
Gross
unrealized
losses
|
Estimated
fair value
|
||||||||||||
Fixed maturities held to maturity
|
||||||||||||||||
U.S. Treasury securities and obligations of U.S. government instrumentalities
|
$
|
615
|
$
|
223
|
$
|
-
|
$
|
838
|
||||||||
Residential mortgage-backed securities
|
165
|
6
|
-
|
171
|
||||||||||||
Certificates of deposit
|
1,080
|
-
|
-
|
1,080
|
||||||||||||
Total
|
$
|
1,860
|
$
|
229
|
$
|
-
|
$
|
2,089
|
|
December 31, 2019
|
|||||||||||||||
|
Amortized
cost
|
Gross
unrealized
gains
|
Gross
unrealized
losses
|
Estimated
fair value
|
||||||||||||
Fixed maturities held to maturity
|
||||||||||||||||
U.S. Treasury securities and obligations of U.S. government instrumentalities
|
$
|
615
|
$
|
158
|
$
|
-
|
$
|
773
|
||||||||
Residential mortgage-backed securities
|
165
|
1
|
-
|
166
|
||||||||||||
Certificates of deposit
|
1,080
|
-
|
-
|
1,080
|
||||||||||||
Total
|
$
|
1,860
|
$
|
159
|
$
|
-
|
$
|
2,019
|
June 30, 2020
|
||||||||||||||||
|
Amortized
cost
|
Gross
unrealized
gains
|
Gross
unrealized
losses
|
Estimated
fair value
|
||||||||||||
|
||||||||||||||||
Other invested assets - Alternative investments
|
$
|
106,790
|
$
|
2,082
|
$
|
(3,347
|
)
|
$
|
105,525
|
|
December 31, 2019
|
|||||||||||||||
|
Amortized
cost
|
Gross
unrealized
gains
|
Gross
unrealized
losses
|
Estimated
fair value
|
||||||||||||
|
||||||||||||||||
Other invested assets - Alternative investments
|
$
|
97,575
|
$
|
3,721
|
$
|
(788
|
)
|
$
|
100,508
|
|
June 30, 2020
|
|||||||||||||||||||||||||||||||||||
Less than 12 months
|
12 months or longer
|
Total
|
||||||||||||||||||||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Loss
|
Number of
Securities
|
Estimated
Fair Value
|
Gross
Unrealized
Loss
|
Number of
Securities
|
Estimated
Fair Value
|
Gross
Unrealized
Loss
|
Number of
Securities
|
|||||||||||||||||||||||||||
Fixed maturities available for sale
|
||||||||||||||||||||||||||||||||||||
Residential mortgage-backed securities
|
$
|
9,137
|
$
|
(263
|
)
|
3
|
$
|
-
|
$
|
-
|
-
|
$
|
9,137
|
$
|
(263
|
)
|
3
|
|||||||||||||||||||
Total fixed maturities
|
$
|
9,137
|
$
|
(263
|
)
|
3
|
$
|
-
|
$
|
-
|
-
|
$
|
9,137
|
$
|
(263
|
)
|
3
|
|||||||||||||||||||
Other invested assets - Alternative investments
|
$
|
56,414
|
$
|
(3,129
|
)
|
14
|
$
|
5,953
|
$
|
(218
|
)
|
2
|
$
|
62,367
|
$
|
(3,347
|
)
|
16
|
|
December 31, 2019
|
|||||||||||||||||||||||||||||||||||
Less than 12 months
|
12 months or longer
|
Total
|
||||||||||||||||||||||||||||||||||
|
Estimated
Fair Value
|
Gross
Unrealized
Loss
|
Number of
Securities
|
Estimated
Fair Value
|
Gross
Unrealized
Loss
|
Number of
Securities
|
Estimated
Fair Value
|
Gross
Unrealized
Loss
|
Number of
Securities
|
|||||||||||||||||||||||||||
Fixed maturities available for sale
|
||||||||||||||||||||||||||||||||||||
Municipal securities
|
$
|
10,656
|
$
|
(22
|
)
|
3
|
$
|
-
|
$
|
-
|
-
|
$
|
10,656
|
$
|
(22
|
)
|
3
|
|||||||||||||||||||
Corporate bonds
|
5,047
|
(74
|
)
|
1
|
-
|
-
|
-
|
5,047
|
(74
|
)
|
1
|
|||||||||||||||||||||||||
Residential mortgage-backed securities
|
79,902
|
(320
|
)
|
16
|
-
|
-
|
-
|
79,902
|
(320
|
)
|
16
|
|||||||||||||||||||||||||
Total fixed maturities
|
$
|
95,605
|
$
|
(416
|
)
|
20
|
$
|
-
|
$
|
-
|
-
|
$
|
95,605
|
$
|
(416
|
)
|
20
|
|||||||||||||||||||
Other invested assets - Alternative investments
|
$
|
24,437
|
$
|
(605
|
)
|
8
|
$
|
10,580
|
$
|
(183
|
)
|
1
|
$
|
35,017
|
$
|
(788
|
)
|
9
|
|
June 30, 2020
|
|||||||
|
Amortized
cost
|
Estimated
fair value
|
||||||
Fixed maturities available for sale
|
||||||||
Due in one year or less
|
$
|
27,639
|
$
|
28,173
|
||||
Due after one year through five years
|
498,068
|
535,717
|
||||||
Due after five years through ten years
|
205,045
|
225,692
|
||||||
Due after ten years
|
176,863
|
211,660
|
||||||
Residential mortgage-backed securities
|
267,075
|
282,777
|
||||||
Collateralized mortgage obligations
|
7,983
|
8,732
|
||||||
|
$
|
1,182,673
|
$
|
1,292,751
|
||||
Fixed maturities held to maturity
|
||||||||
Due in one year or less
|
$
|
1,080
|
$
|
1,080
|
||||
Due after ten years
|
615
|
838
|
||||||
Residential mortgage-backed securities
|
165
|
171
|
||||||
|
$
|
1,860
|
$
|
2,089
|
(4) |
Realized and Unrealized Gains (Losses)
|
|
Three months ended
June 30,
|
Six months ended
June 30,
|
||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
||||||||||||
Realized gains (losses)
|
||||||||||||||||
Fixed maturity securities:
|
||||||||||||||||
Securities available for sale:
|
||||||||||||||||
Gross gains
|
$
|
777
|
$
|
1,775
|
$
|
1,551
|
$
|
2,647
|
||||||||
Gross losses
|
-
|
(1
|
)
|
(6
|
)
|
(319
|
)
|
|||||||||
Total fixed securities
|
777
|
1,774
|
1,545
|
2,328
|
||||||||||||
Equity investments:
|
||||||||||||||||
Gross gains
|
60
|
829
|
990
|
2,131
|
||||||||||||
Gross losses
|
(1,158
|
)
|
(408
|
)
|
(2,770
|
)
|
(1,045
|
)
|
||||||||
Gross losses from impaired securities
|
-
|
-
|
(678
|
)
|
-
|
|||||||||||
Total equity investments
|
(1,098
|
)
|
421
|
(2,458
|
)
|
1,086
|
||||||||||
Other invested assets:
|
||||||||||||||||
Gross gains
|
100
|
189
|
226
|
321
|
||||||||||||
Gross losses
|
-
|
(20
|
)
|
-
|
(56
|
)
|
||||||||||
Total other invested assets
|
100
|
169
|
226
|
265
|
||||||||||||
Net realized investment (losses) gains
|
$
|
(221
|
)
|
$
|
2,364
|
$
|
(687
|
)
|
$
|
3,679
|
|
Three months ended
June 30,
|
Six months ended
June 30,
|
||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
||||||||||||
Changes in net unrealized gains (losses):
|
||||||||||||||||
Recognized in accumulated other comprehensive income (loss):
|
||||||||||||||||
Fixed maturities – available for sale
|
$
|
20,482
|
$
|
19,461
|
$
|
40,238
|
$
|
36,551
|
||||||||
Other invested assets
|
(4,766
|
)
|
99
|
(4,198
|
)
|
672
|
||||||||||
|
$
|
15,716
|
$
|
19,560
|
$
|
36,040
|
$
|
37,223
|
||||||||
Not recognized in the consolidated financial statements:
|
||||||||||||||||
Fixed maturities – held to maturity
|
$
|
(2
|
)
|
$
|
21
|
$
|
70
|
$
|
36
|
(5) |
Premiums and Other Receivables, Net
|
|
June 30,
2020
|
December 31,
2019
|
||||||
Premium
|
$
|
145,775
|
$
|
188,861
|
||||
Self-funded group receivables
|
23,946
|
28,672
|
||||||
FEHBP
|
13,053
|
13,894
|
||||||
Agent balances
|
36,344
|
30,784
|
||||||
Accrued interest
|
10,595
|
11,307
|
||||||
Reinsurance recoverable
|
235,291
|
239,767
|
||||||
Other
|
135,938
|
110,952
|
||||||
|
600,942
|
624,237
|
||||||
Less allowance for doubtful receivables:
|
||||||||
Premium
|
41,406
|
36,622
|
||||||
Other
|
12,327
|
19,923
|
||||||
|
53,733
|
56,545
|
||||||
Total premium and other receivables, net
|
$
|
547,209
|
$
|
567,692
|
(6) |
Property and Equipment, Net
|
|
June 30,
|
December 31,
|
||||||
|
2020
|
2019
|
||||||
|
||||||||
Land
|
$
|
10,976
|
$
|
10,976
|
||||
Buildings and leasehold improvements
|
129,070
|
92,752
|
||||||
Office furniture and equipment
|
31,420
|
27,878
|
||||||
Computer equipment and software
|
132,405
|
133,922
|
||||||
Automobiles
|
700
|
761
|
||||||
|
304,571
|
266,289
|
||||||
Less accumulated depreciation and amortization
|
177,886
|
177,701
|
||||||
Property and equipment, net
|
$
|
126,685
|
$
|
88,588
|
(7) |
Fair Value Measurements
|
|
June 30, 2020
|
|||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||||||
|
||||||||||||||||
Fixed maturity securities available for sale
|
||||||||||||||||
Obligations of government-sponsored enterprises
|
$
|
-
|
$
|
18,032
|
$
|
-
|
$
|
18,032
|
||||||||
U.S. Treasury securities and obligations of U.S government instrumentalities
|
111,967
|
-
|
-
|
111,967
|
||||||||||||
Municipal securities
|
-
|
644,482
|
-
|
644,482
|
||||||||||||
Corporate bonds
|
-
|
226,761
|
-
|
226,761
|
||||||||||||
Residential agency mortgage-backed securities
|
-
|
282,777
|
-
|
282,777
|
||||||||||||
Collateralized mortgage obligations
|
-
|
8,732
|
-
|
8,732
|
||||||||||||
Total fixed maturities
|
$
|
111,967
|
$
|
1,180,784
|
$
|
-
|
$
|
1,292,751
|
||||||||
Equity investments
|
$
|
185,308
|
$
|
154,059
|
$
|
5,237
|
$
|
344,604
|
|
December 31, 2019
|
|||||||||||||||
|
Level 1
|
Level 2
|
Level 3
|
Total
|
||||||||||||
|
||||||||||||||||
Fixed maturity securities
|
||||||||||||||||
Obligations of government-sponsored enterprises
|
$
|
-
|
$
|
17,686
|
$
|
-
|
$
|
17,686
|
||||||||
U.S. Treasury securities and obligations of U.S government instrumentalities
|
107,009
|
-
|
-
|
107,009
|
||||||||||||
Municipal securities
|
-
|
629,764
|
-
|
629,764
|
||||||||||||
Corporate bonds
|
-
|
208,743
|
-
|
208,743
|
||||||||||||
Residential agency mortgage-backed securities
|
-
|
270,536
|
-
|
270,536
|
||||||||||||
Collateralized mortgage obligations
|
-
|
9,145
|
-
|
9,145
|
||||||||||||
Total fixed maturities
|
$
|
107,009
|
$
|
1,135,874
|
$
|
-
|
$
|
1,242,883
|
||||||||
Equity investments
|
$
|
177,136
|
$
|
105,180
|
$
|
5,209
|
$
|
287,525
|
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
|
||||||||
|
Three months ended
|
Six months ended
|
||||||
June 30, 2020
|
June 30, 2020
|
|||||||
Beginning Balance
|
$
|
5,239
|
$
|
5,209
|
||||
Unrealized in other accumulated comprehensive income
|
(2
|
)
|
28
|
|||||
Ending Balance
|
$
|
5,237
|
$
|
5,237
|
(8) |
Claim Liabilities
|
|
Six months ended
June 30, 2020
|
|||||||||||
|
Managed
Care
|
Other
Business
Segments *
|
Consolidated
|
|||||||||
|
||||||||||||
|
||||||||||||
Claim liabilities at beginning of period
|
$
|
341,277
|
$
|
367,981
|
$
|
709,258
|
||||||
Reinsurance recoverable on claim liabilities
|
-
|
(137,017
|
)
|
(137,017
|
)
|
|||||||
Net claim liabilities at beginning of period
|
341,277
|
230,964
|
572,241
|
|||||||||
Claims incurred
|
||||||||||||
Current period insured events
|
1,308,194
|
58,559
|
1,366,753
|
|||||||||
Prior period insured events
|
(3,392
|
)
|
(9,821
|
)
|
(13,213
|
)
|
||||||
Total
|
1,304,802
|
48,738
|
1,353,540
|
|||||||||
Payments of losses and loss-adjustment expenses
|
||||||||||||
Current period insured events
|
1,039,871
|
23,660
|
1,063,531
|
|||||||||
Prior period insured events
|
257,073
|
27,952
|
285,025
|
|||||||||
Total
|
1,296,944
|
51,612
|
1,348,556
|
|||||||||
Net claim liabilities at end of period
|
349,135
|
228,090
|
577,225
|
|||||||||
Reinsurance recoverable on claim liabilities
|
-
|
147,989
|
147,989
|
|||||||||
Claim liabilities at end of period
|
$
|
349,135
|
$
|
376,079
|
$
|
725,214
|
* |
Other Business Segments include the Life Insurance and Property and Casualty segments, as well as intersegment eliminations.
|
|
Six months ended
June 30, 2019
|
|||||||||||
|
Managed
Care
|
Other
Business
Segments *
|
Consolidated
|
|||||||||
|
||||||||||||
|
||||||||||||
Claim liabilities at beginning of period
|
$
|
394,226
|
$
|
542,563
|
$
|
936,789
|
||||||
Reinsurance recoverable on claim liabilities
|
-
|
(315,543
|
)
|
(315,543
|
)
|
|||||||
Net claim liabilities at beginning of period
|
394,226
|
227,020
|
621,246
|
|||||||||
Claims incurred
|
||||||||||||
Current period insured events
|
1,288,235
|
57,020
|
1,345,255
|
|||||||||
Prior period insured events
|
(27,588
|
)
|
(6,167
|
)
|
(33,755
|
)
|
||||||
Total
|
1,260,647
|
50,853
|
1,311,500
|
|||||||||
Payments of losses and loss-adjustment expenses
|
||||||||||||
Current period insured events
|
954,147
|
23,429
|
977,576
|
|||||||||
Prior period insured events
|
277,624
|
26,581
|
304,205
|
|||||||||
Total
|
1,231,771
|
50,010
|
1,281,781
|
|||||||||
Net claim liabilities at end of period
|
423,102
|
227,863
|
650,965
|
|||||||||
Reinsurance recoverable on claim liabilities
|
-
|
214,462
|
214,462
|
|||||||||
Claim liabilities at end of period
|
$
|
423,102
|
$
|
442,325
|
$
|
865,427
|
* |
Other Business Segments include the Life Insurance and Property and Casualty segments, as well as intersegment eliminations.
|
Incurred Year
|
Total of IBNR Liabilities Plus Expected
Development on Reported Claims
|
|||
2019
|
$
|
25,985
|
||
2020
|
268,323
|
(9) |
Borrowings
|
|
June 30, 2020
|
December 31, 2019
|
||||||
|
||||||||
Secured loan payable of $11,187, payable in monthly installments of $137 through October 1, 2023, plus interest at a rate reset periodically of 100 basis points over selected LIBOR maturity (which was 1.18% at June 30, 2020).
|
$
|
5,447
|
$
|
6,267
|
||||
Secured loan payable of $20,150, payable in monthly installments of $84 through January 1, 2024, plus interest at a rate reset periodically of 275 basis points over selected LIBOR maturity (which was 4.20% at June 30, 2020).
|
16,707
|
17,211
|
||||||
Secured loan payable of $4,116, payable in monthly installments of $49 through January 1, 2024, plus interest at a rate reset periodically of 325 basis points over selected LIBOR maturity (which was 4.70% at June 30, 2020).
|
2,107
|
2,401
|
||||||
Secured loan payable of $31,350, payable in monthly installments of $105 through May 1, 2025, plus interest at prime rate (which was 3.25% at June 30, 2020). Last payment of $25,185 due on June 19, 2025.
|
31,350
|
-
|
||||||
Total borrowings
|
55,611
|
25,879
|
||||||
|
||||||||
Less: unamortized debt issuance costs
|
671
|
185
|
||||||
|
$
|
54,940
|
$
|
25,694
|
Remaining of 2020
|
$
|
2,245
|
||
2021
|
4,490
|
|||
2022
|
4,490
|
|||
2023
|
4,196
|
|||
2024
|
14,484
|
|||
Thereafter
|
25,706
|
|||
|
$
|
55,611
|
• |
In August 2019, Triple-S Salud, Inc. (TSS) and Triple-S Vida, Inc. (TSV) became members of the FHLBNY, which provides access to collateralized advances. The borrowing capacity of TSS and TSV is up to 30% of their admitted assets as disclosed in the most recent filing with the Commissioner of Insurance but is constrained by the amount of collateral held at the FHLBNY (see Note 3). As of June 30, 2020, the borrowing capacity was approximately $120,074 for TSS and $91,943 for TSV. As of December 31, 2019, the borrowing capacity was approximately $82,200 for TSS and $48,900 for TSV. The outstanding balance as of June 30, 2020 for TSV is $15,000 . TSS had no outstanding balance as of June 30, 2020. The outstanding balance as of December 31, 2019 for TSS and TSV was $25,000 and $29,000, respectively. The average interest rate of the outstanding balance is 0.41% and 1.79% as of June 30, 2020 and December 31, 2019, respectively.
|
• |
Triple-S Advantage, Inc. (TSA) has a $10,000 revolving loan agreement with a commercial bank in Puerto Rico. This line of credit has an interest rate of 30-day LIBOR plus 250 basis points and contains certain financial and non-financial covenants that are customary for this type of facility. This line of credit matured on June 30, 2020 and was renewed for an additional year. As of June 30, 2020, there is no outstanding balance.
|
(10) |
Pension Plan
|
|
Three months ended
June 30,
|
Six months ended
June 30,
|
||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
||||||||||||
Components of net periodic benefit cost:
|
||||||||||||||||
Interest cost
|
$
|
1,540
|
$
|
1,741
|
$
|
3,080
|
$
|
3,482
|
||||||||
Expected return on assets
|
(2,209
|
)
|
(2,217
|
)
|
(4,418
|
)
|
(4,434
|
)
|
||||||||
Amortization of actuarial loss
|
244
|
90
|
488
|
179
|
||||||||||||
Settlement loss
|
356
|
375
|
712
|
750
|
||||||||||||
Net periodic benefit cost
|
$
|
(69
|
)
|
$
|
(11
|
)
|
$
|
(138
|
)
|
$
|
(23
|
)
|
(11) |
Stock Repurchase Program
|
(12) |
Reinsurance
|
•
|
Casualty excess of loss treaty provides reinsurance for losses up to $20,000, subject to a retention of $225.
|
•
|
Medical malpractice excess of loss treaty provides reinsurance for losses up to $3,000, subject to a retention of $150.
|
•
|
Property reinsurance treaty includes proportional cessions and a per risk excess of loss contract limiting losses to $400 in $30,000 risks.
|
•
|
Catastrophe protection is purchased limiting losses to $5,000 per event with losses up to approximately $809,000 in a $814,000 event.
|
(13) |
Leases
|
Remaning of 2020
|
$
|
2,063
|
||
2021
|
3,935
|
|||
2022
|
3,371
|
|||
2023
|
2,273
|
|||
2024
|
1,798
|
|||
Thereafter
|
3,415
|
|||
Total lease payments
|
16,855
|
|||
Less: imputed interest
|
(2,200
|
)
|
||
Total
|
$
|
14,655
|
|
Six months ended
|
|||
June 30, 2020
|
||||
Operating lease cost
|
$
|
1,903
|
||
Short-term lease cost
|
629
|
|||
Total lease cost
|
$
|
2,532
|
Remaining of 2020
|
$
|
945
|
||
2021
|
1,909
|
|||
2022
|
1,947
|
|||
2023
|
1,986
|
|||
2024
|
2,026
|
|||
Thereafter
|
2,625
|
|||
Total
|
$
|
11,438
|
(14) |
Comprehensive Income (Loss)
|
|
Three months ended
|
Six months ended
|
||||||||||||||
|
June 30,
|
June 30,
|
||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
||||||||||||
Net Unrealized Gain on Securities
|
||||||||||||||||
Beginning Balance
|
$
|
73,709
|
$
|
40,749
|
$
|
57,830
|
$
|
27,308
|
||||||||
Other comprehensive income before reclassifications
|
10,681
|
16,820
|
26,730
|
31,313
|
||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss)
|
720
|
(1,891
|
)
|
550
|
(2,943
|
)
|
||||||||||
Net current period change
|
11,401
|
14,929
|
27,280
|
28,370
|
||||||||||||
Ending Balance
|
85,110
|
55,678
|
85,110
|
55,678
|
||||||||||||
Liability for Pension Benefits Beginning Balance
|
(28,314
|
)
|
(24,190
|
)
|
(28,467
|
)
|
(24,246
|
)
|
||||||||
Amounts reclassified from accumulated other comprehensive income
|
153
|
56
|
306
|
112
|
||||||||||||
Ending Balance
|
(28,161
|
)
|
(24,134
|
)
|
(28,161
|
)
|
(24,134
|
)
|
||||||||
Accumulated Other Comprehensive Income Beginning Balance
|
45,395
|
16,559
|
29,363
|
3,062
|
||||||||||||
Other comprehensive income before reclassifications
|
10,681
|
16,820
|
26,730
|
31,313
|
||||||||||||
Amounts reclassified from accumulated other comprehensive income (loss)
|
873
|
(1,835
|
)
|
856
|
(2,831
|
)
|
||||||||||
Net current period change
|
11,554
|
14,985
|
27,586
|
28,482
|
||||||||||||
Ending Balance
|
$
|
56,949
|
$
|
31,544
|
$
|
56,949
|
$
|
31,544
|
(15) |
Share-Based Compensation
|
(16) |
Net Income Available to Stockholders and Net Income per Share
|
|
Three months ended
June 30,
|
Six months ended
June 30,
|
||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
||||||||||||
Numerator for earnings per share:
|
||||||||||||||||
Net income attributable to TSM available to stockholders
|
$
|
43,599
|
$
|
30,931
|
$
|
17,454
|
$
|
65,717
|
||||||||
Denominator for basic earnings per share:
|
||||||||||||||||
Weighted average of common shares
|
23,193,626
|
22,830,399
|
23,287,787
|
22,794,297
|
||||||||||||
Effect of dilutive securities
|
77,677
|
64,601
|
85,198
|
72,394
|
||||||||||||
Denominator for diluted earnings per share
|
23,271,303
|
22,895,000
|
23,372,985
|
22,866,691
|
||||||||||||
Basic net income per share attributable to TSM
|
$
|
1.88
|
$
|
1.35
|
$
|
0.75
|
$
|
2.88
|
||||||||
Diluted net income per share attributable to TSM
|
$
|
1.87
|
$
|
1.35
|
$
|
0.75
|
$
|
2.87
|
(17) |
Contingencies
|
(18) |
Segment Information
|
|
Three months ended
June 30,
|
Six months ended
June 30,
|
||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
||||||||||||
Operating revenues:
|
||||||||||||||||
Managed Care:
|
||||||||||||||||
Premiums earned, net
|
$
|
788,773
|
$
|
793,355
|
$
|
1,598,059
|
$
|
1,498,405
|
||||||||
Administrative service fees
|
2,809
|
2,456
|
5,003
|
5,088
|
||||||||||||
Intersegment premiums/service fees
|
1,076
|
1,645
|
2,719
|
3,129
|
||||||||||||
Net investment income
|
4,690
|
5,479
|
9,698
|
11,357
|
||||||||||||
Total managed care
|
797,348
|
802,935
|
1,615,479
|
1,517,979
|
||||||||||||
Life Insurance:
|
||||||||||||||||
Premiums earned, net
|
47,523
|
44,511
|
93,709
|
88,233
|
||||||||||||
Intersegment premiums
|
545
|
508
|
1,036
|
986
|
||||||||||||
Net investment income
|
6,795
|
6,822
|
13,725
|
13,382
|
||||||||||||
Total life insurance
|
54,863
|
51,841
|
108,470
|
102,601
|
||||||||||||
Property and Casualty Insurance:
|
||||||||||||||||
Premiums earned, net
|
22,239
|
21,627
|
42,664
|
40,857
|
||||||||||||
Intersegment premiums
|
154
|
154
|
307
|
307
|
||||||||||||
Net investment income
|
2,323
|
2,384
|
4,448
|
4,871
|
||||||||||||
Total property and casualty insurance
|
24,716
|
24,165
|
47,419
|
46,035
|
||||||||||||
Other segments: *
|
||||||||||||||||
Intersegment service revenues
|
2,007
|
2,007
|
5,042
|
3,973
|
||||||||||||
Operating revenues from external sources
|
303
|
1,591
|
4,342
|
3,168
|
||||||||||||
Total other segments
|
2,310
|
3,598
|
9,384
|
7,141
|
||||||||||||
Total business segments
|
879,237
|
882,539
|
1,780,752
|
1,673,756
|
||||||||||||
TSM operating revenues from external sources
|
7
|
377
|
255
|
828
|
||||||||||||
Elimination of intersegment premiums/service fees
|
(1,775
|
)
|
(2,307
|
)
|
(4,062
|
)
|
(4,422
|
)
|
||||||||
Elimination of intersegment service revenues
|
(2,007
|
)
|
(2,007
|
)
|
(5,042
|
)
|
(3,973
|
)
|
||||||||
Consolidated operating revenues
|
$
|
875,462
|
$
|
878,602
|
$
|
1,771,903
|
$
|
1,666,189
|
* |
Includes segments that are not required to be reported separately, primarily the health clinics.
|
|
Three months ended
June 30,
|
Six months ended
June 30,
|
||||||||||||||
|
2020
|
2019
|
2020
|
2019
|
||||||||||||
Operating income (loss):
|
||||||||||||||||
Managed care
|
$
|
29,322
|
$
|
29,302
|
$
|
43,489
|
$
|
51,412
|
||||||||
Life insurance
|
9,457
|
5,215
|
14,506
|
10,855
|
||||||||||||
Property and casualty insurance
|
6,777
|
4,784
|
6,535
|
8,338
|
||||||||||||
Other segments *
|
(2,409
|
)
|
(730
|
)
|
(2,913
|
)
|
(1,122
|
)
|
||||||||
Total business segments
|
43,147
|
38,571
|
61,617
|
69,483
|
||||||||||||
TSM operating revenues from external sources
|
7
|
377
|
255
|
828
|
||||||||||||
TSM unallocated operating expenses
|
(1,841
|
)
|
(3,137
|
)
|
(3,244
|
)
|
(5,169
|
)
|
||||||||
Elimination of TSM intersegment charges
|
2,403
|
2,403
|
4,806
|
4,806
|
||||||||||||
Consolidated operating income
|
43,716
|
38,214
|
63,434
|
69,948
|
||||||||||||
Consolidated net realized investment (losses) gains
|
(221
|
)
|
2,364
|
(687
|
)
|
3,679
|
||||||||||
Consolidated net unrealized investment gains (losses) on equity investments
|
28,338
|
3,323
|
(28,468
|
)
|
22,992
|
|||||||||||
Consolidated interest expense
|
(1,864
|
)
|
(1,831
|
)
|
(3,717
|
)
|
(3,619
|
)
|
||||||||
Consolidated other income, net
|
801
|
1,705
|
4,406
|
2,874
|
||||||||||||
Consolidated income before taxes
|
$
|
70,770
|
$
|
43,775
|
$
|
34,968
|
$
|
95,874
|
||||||||
|
||||||||||||||||
Depreciation and amortization expense:
|
||||||||||||||||
Managed care
|
$
|
2,930
|
$
|
2,792
|
$
|
5,976
|
$
|
5,549
|
||||||||
Life insurance
|
308
|
273
|
580
|
545
|
||||||||||||
Property and casualty insurance
|
91
|
86
|
203
|
180
|
||||||||||||
Other segments*
|
352
|
193
|
673
|
378
|
||||||||||||
Total business segments
|
3,681
|
3,344
|
7,432
|
6,652
|
||||||||||||
TSM depreciation expense
|
156
|
196
|
312
|
393
|
||||||||||||
Consolidated depreciation and amortization expense
|
$
|
3,837
|
$
|
3,540
|
$
|
7,744
|
$
|
7,045
|
* |
Includes segments that are not required to be reported separately, primarily the health clinics.
|
|
June 30,
2020
|
December 31,
2019
|
||||||
Assets:
|
||||||||
Managed care
|
$
|
1,344,379
|
$
|
1,190,538
|
||||
Life insurance
|
1,030,522
|
981,370
|
||||||
Property and casualty insurance
|
603,537
|
592,758
|
||||||
Other segments *
|
30,304
|
28,346
|
||||||
Total business segments
|
3,008,742
|
2,793,012
|
||||||
Unallocated amounts related to TSM:
|
||||||||
Cash, cash equivalents, and investments
|
20,214
|
28,167
|
||||||
Property and equipment, net
|
65,461
|
25,623
|
||||||
Other assets
|
46,134
|
37,176
|
||||||
|
131,809
|
90,966
|
||||||
Elimination entries-intersegment receivables and others
|
(119,121
|
)
|
(65,152
|
)
|
||||
Consolidated total assets
|
$
|
3,021,430
|
$
|
2,818,826
|
* |
Includes segments that are not required to be reported separately, primarily the health clinics.
|
(19) |
Subsequent Events
|
Item 2. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
As of June 30,
|
|||||||
2020
|
2019
|
|||||||
Managed care enrollment:
|
||||||||
Commercial 1
|
433,471
|
436,407
|
||||||
Medicare
|
134,601
|
128,670
|
||||||
Medicaid
|
364,157
|
364,495
|
||||||
Total
|
932,229
|
929,572
|
||||||
Managed care enrollment by funding arrangement:
|
||||||||
Fully-insured
|
823,247
|
811,594
|
||||||
Self-insured
|
108,982
|
117,978
|
||||||
Total
|
932,229
|
929,572
|
(1) |
Commercial membership includes corporate accounts, self-funded employers, individual accounts, Medicare Supplement, Federal government employees and local government employees.
|
|
Three months ended
|
Six months ended
|
||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
(dollar amounts in millions)
|
2020
|
2019
|
2020
|
2019
|
||||||||||||
Revenues:
|
||||||||||||||||
Premiums earned, net
|
$
|
858.5
|
$
|
859.5
|
$
|
1,734.4
|
$
|
1,627.5
|
||||||||
Administrative service fees
|
2.8
|
2.5
|
5.0
|
5.1
|
||||||||||||
Net investment income
|
13.8
|
15.0
|
28.1
|
30.4
|
||||||||||||
Other operating revenues
|
0.4
|
1.6
|
4.4
|
3.2
|
||||||||||||
Total operating revenues
|
875.5
|
878.6
|
1,771.9
|
1,666.2
|
||||||||||||
Net realized investment (losses) gains
|
(0.2
|
)
|
2.4
|
(0.7
|
)
|
3.6
|
||||||||||
Net unrealized investment gains (losses) on equity investments
|
28.3
|
3.3
|
(28.5
|
)
|
23.0
|
|||||||||||
Other income, net
|
0.8
|
1.7
|
4.4
|
2.9
|
||||||||||||
Total revenues
|
904.4
|
886.0
|
1,747.1
|
1,695.7
|
||||||||||||
Benefits and expenses:
|
||||||||||||||||
Claims incurred
|
653.1
|
706.3
|
1,367.6
|
1,329.5
|
||||||||||||
Operating expenses
|
178.7
|
134.1
|
340.9
|
266.7
|
||||||||||||
Total operating expenses
|
831.8
|
840.4
|
1,708.5
|
1,596.2
|
||||||||||||
Interest expense
|
1.8
|
1.8
|
3.7
|
3.6
|
||||||||||||
Total benefits and expenses
|
833.6
|
842.2
|
1,712.2
|
1,599.8
|
||||||||||||
Income before taxes
|
70.8
|
43.8
|
34.9
|
95.9
|
||||||||||||
Income tax expense
|
27.2
|
12.9
|
17.5
|
30.2
|
||||||||||||
Net income attributable to TSM
|
$
|
43.6
|
$
|
30.9
|
$
|
17.4
|
$
|
65.7
|
|
Three months ended
|
Six months ended
|
||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
(dollar amounts in millions)
|
2020
|
2019
|
2020
|
2019
|
||||||||||||
Operating revenues:
|
||||||||||||||||
Medical premiums earned, net:
|
||||||||||||||||
Medicare
|
$
|
372.4
|
$
|
366.0
|
$
|
760.2
|
$
|
698.6
|
||||||||
Medicaid
|
221.1
|
227.0
|
442.0
|
401.4
|
||||||||||||
Commercial
|
195.8
|
200.8
|
396.9
|
399.3
|
||||||||||||
Medical premiums earned, net
|
789.3
|
793.8
|
1,599.1
|
1,499.3
|
||||||||||||
Administrative service fees
|
3.4
|
3.6
|
6.7
|
7.3
|
||||||||||||
Net investment income
|
4.7
|
5.5
|
9.7
|
11.4
|
||||||||||||
Total operating revenues
|
797.4
|
802.9
|
1,615.5
|
1,518.0
|
||||||||||||
Medical operating costs:
|
||||||||||||||||
Medical claims incurred
|
627.0
|
670.7
|
1,304.8
|
1,260.7
|
||||||||||||
Medical operating expenses
|
141.1
|
102.9
|
267.2
|
205.9
|
||||||||||||
Total medical operating costs
|
768.1
|
773.6
|
1,572.0
|
1,466.6
|
||||||||||||
Medical operating income
|
$
|
29.3
|
$
|
29.3
|
$
|
43.5
|
$
|
51.4
|
||||||||
Additional data:
|
||||||||||||||||
Member months enrollment:
|
||||||||||||||||
Commercial:
|
||||||||||||||||
Fully-insured
|
975,212
|
955,463
|
1,953,554
|
1,908,515
|
||||||||||||
Self-funded
|
327,030
|
353,961
|
657,262
|
716,451
|
||||||||||||
Total commercial
|
1,302,242
|
1,309,424
|
2,610,816
|
2,624,966
|
||||||||||||
Medicare
|
405,203
|
385,835
|
813,110
|
769,443
|
||||||||||||
Medicaid
|
1,077,456
|
1,092,132
|
2,145,472
|
2,121,868
|
||||||||||||
Total member months
|
2,784,901
|
2,787,391
|
5,569,398
|
5,516,277
|
||||||||||||
Medical loss ratio
|
79.4
|
%
|
84.5
|
%
|
81.6
|
%
|
84.1
|
%
|
||||||||
Operating expense ratio
|
17.8
|
%
|
12.9
|
%
|
16.6
|
%
|
13.7
|
%
|
• |
Premiums generated by the Medicare business increased by $6.4 million, or 1.7% to $372.4 million, mostly due to an increase in enrollment of approximately 19,000 member months, which primarily reflects a more competitive product offering, and an increase in the average membership risk score. This increase in premiums earned was partially offset by the recognition of estimated premium rebates due to the lower MLR resulting from the decreased utilization of services following the pandemic-related lockdown.
|
• |
Premiums generated by the Medicaid business decreased by $5.9 million, or 2.6% to $221.1 million, primarily reflecting lower membership of approximately 15,000 member months. In addition, the 2019 quarter includes retroactive premiums related to adjustments to the premium rates for high cost high need members as part of an ongoing reconciliation with ASES.
|
• |
Premiums generated by the Commercial business decreased by $5.0 million, or 2.5%, to $195.8 million, mainly reflecting lower average premium rates and the recognition of estimated premium rebates due to the lower MLR resulting from the decreased utilization of services following the government enforced lockdown due to the COVID-19 pandemic. These decreases were partially offset by an increase in fully-insured enrollment during the quarter by approximately 20,000 member months and the reinstatement of the HIP fee pass-through in 2020.
|
• |
Claims incurred in the Medicare business decreased by $13.9 million, or 4.6%, during the 2020 period and its MLR decreased 520 basis points to 77.2%. The lower MLR mostly reflects lower utilization of services as the result of the government enforced lockdown due to the COVID-19 pandemic, which was in force during most of the second quarter, partially offset by improved benefits in the 2020 product offerings and the impact of the previously mentioned estimated premium rebates.
|
• |
Claims incurred in the Medicaid business increased by $0.3 million, or 0.1%, during the 2020 period. The MLR, at 93.7%, was 260 basis point higher than the same period last year. The higher MLR mostly reflects the impact of the retroactive premiums adjustment in the second quarter of 2019 mentioned above.
|
• |
Claims incurred in the Commercial business decreased by $30.1 million, or 18.6%, during 2020 and its MLR decreased 1,340 basis points, to 67.5%. The lower MLR mostly reflects the impact of the lower utilization as a result of the lockdown and the reinstatement of the HIP fee pass-through in 2020. These decreases were partially offset by the impact of the previously mentioned estimated premium rebates and the impact in 2019 of favorable prior period reserve development.
|
• |
Premiums generated by the Medicare business increased by $61.6 million, or 8.8%, to $760.2 million, mostly due to higher average premium rates, reflecting an increase in the average membership risk score revenue in 2020, and higher member months enrollment by approximately 44,000. These increases were partially offset by the recognition of estimated premium rebates due to the lower MLR resulting from the decreased utilization of services as the result of the government enforced lockdown due to the COVID-19 pandemic.
|
• |
Premiums generated by the Medicaid business increased by $40.6 million, or 10.1% to $442.0 million, primarily reflecting higher average premium rates, an increase in enrollment of approximately 24,000 member months, the reinstatement of the HIP fee pass-through in 2020, and the impact of the profit sharing accrual recorded in 2019. These increases were partially offset due to the impact recognized in the 2019 period, of the retroactive premiums related to adjustments to the premium rates for high cost high need members as part of an ongoing reconciliation with ASES.
|
• |
Premiums generated by the Commercial business decreased by $2.4 million, or 0.6%, to $396.9 million. This fluctuation primarily reflects lower average premium rates and the recognition of estimated premium rebates due to the lower MLR resulting from the decreased utilization of services as the result of the government enforced lockdown. These decreases were partially offset by higher fully-insured enrollment during the quarter by approximately 45,000 member months, and the reinstatement of the HIP fee pass-through in 2020.
|
• |
Claims incurred in the Medicare business increased by $38.8 million, or 6.8%, during the 2020 period and its MLR decreased 150 basis points, to 80.0%. The increase in claim cost is due to higher member months partially offset by the loser MLR. The lower MLR mostly reflects lower utilization of services as the result of the government enforced lockdown due to the COVID-19 pandemic, which was in force during most of the second quarter, partially offset by improved benefits in the 2020 product offerings. In addition, the 2019 MLR was favorably impacted by prior period reserve development.
|
• |
The Managed Care claims incurred in the Medicaid business increased by $42.3 million, or 11.6%, during 2020 and its MLR increased 130 basis points, to 92.0%. The higher MLR mostly reflects the impact of the retroactive premiums adjustment in the second quarter of 2019 mentioned above and an unfavorable prior period reserve development in the 2020 period.
|
• |
Claims incurred in the Commercial business decreased by $37.0 million, or 11.3%, during 2020 and its MLR decreased 890 basis points, to 73.0%. These decreases mostly result from lower utilization related to the COVID-19 lockdown and the impact in the MLR of the reinstatement of the HIP fee pass-through in 2020. These decreases were partially offset by the impact of the previously mentioned estimated premium rebates, higher fully-insured enrollment, and the impact in 2019 of favorable prior period reserve development.
|
|
Three months ended
|
Six months ended
|
||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
(dollar amounts in millions)
|
2020
|
2019
|
2020
|
2019
|
||||||||||||
Operating revenues:
|
||||||||||||||||
Premiums earned, net:
|
||||||||||||||||
Premiums earned
|
$
|
50.6
|
$
|
46.8
|
$
|
99.6
|
$
|
92.4
|
||||||||
Assumed earned premiums
|
-
|
0.3
|
-
|
1.0
|
||||||||||||
Ceded premiums earned
|
(2.5
|
)
|
(2.1
|
)
|
(4.8
|
)
|
(4.2
|
)
|
||||||||
Premiums earned, net
|
48.1
|
45.0
|
94.8
|
89.2
|
||||||||||||
Net investment income
|
6.8
|
6.8
|
13.7
|
13.4
|
||||||||||||
Total operating revenues
|
54.9
|
51.8
|
108.5
|
102.6
|
||||||||||||
Operating costs:
|
||||||||||||||||
Policy benefits and claims incurred
|
20.6
|
27.3
|
48.0
|
53.3
|
||||||||||||
Underwriting and other expenses
|
24.8
|
19.3
|
46.0
|
38.4
|
||||||||||||
Total operating costs
|
45.4
|
46.6
|
94.0
|
91.7
|
||||||||||||
Operating income
|
$
|
9.5
|
$
|
5.2
|
$
|
14.5
|
$
|
10.9
|
||||||||
Additional data:
|
||||||||||||||||
Loss ratio
|
42.8
|
%
|
60.7
|
%
|
50.6
|
%
|
59.8
|
%
|
||||||||
Operating expense ratio
|
51.6
|
%
|
42.9
|
%
|
48.5
|
%
|
43.0
|
%
|
|
Three months ended
|
Six months ended
|
||||||||||||||
June 30,
|
June 30,
|
|||||||||||||||
(dollar amounts in millions)
|
2020
|
2019
|
2020
|
2019
|
||||||||||||
Operating revenues:
|
||||||||||||||||
Premiums earned, net:
|
||||||||||||||||
Premiums written
|
$
|
38.4
|
$
|
36.4
|
$
|
71.6
|
$
|
67.3
|
||||||||
Premiums ceded
|
(14.3
|
)
|
(10.3
|
)
|
(30.7
|
)
|
(23.7
|
)
|
||||||||
Change in unearned premiums
|
(1.7
|
)
|
(4.3
|
)
|
2.1
|
(2.5
|
)
|
|||||||||
Premiums earned, net
|
22.4
|
21.8
|
43.0
|
41.1
|
||||||||||||
Net investment income
|
2.3
|
2.4
|
4.4
|
4.9
|
||||||||||||
Total operating revenues
|
24.7
|
24.2
|
47.4
|
46.0
|
||||||||||||
Operating costs:
|
||||||||||||||||
Claims incurred
|
6.5
|
9.4
|
17.4
|
18.0
|
||||||||||||
Underwriting and other expenses
|
11.5
|
10.0
|
23.5
|
19.7
|
||||||||||||
Total operating costs
|
18.0
|
19.4
|
40.9
|
37.7
|
||||||||||||
Operating income
|
$
|
6.7
|
$
|
4.8
|
$
|
6.5
|
$
|
8.3
|
||||||||
Additional data:
|
||||||||||||||||
Loss ratio
|
29.0
|
%
|
43.1
|
%
|
40.5
|
%
|
43.8
|
%
|
||||||||
Operating expense ratio
|
51.3
|
%
|
45.9
|
%
|
54.7
|
%
|
47.9
|
%
|
|
Six months ended
|
|||||||
June 30,
|
||||||||
(dollar amounts in millions)
|
2020
|
2019
|
||||||
Sources (uses) of cash:
|
||||||||
Cash provided by operating activities
|
$
|
170.3
|
$
|
26.3
|
||||
Net (purchases) proceeds of investment securities
|
(105.6
|
)
|
25.5
|
|||||
Net capital expenditures
|
(45.9
|
)
|
(10.7
|
)
|
||||
Capital contribution on equity method investees
|
(4.9
|
)
|
-
|
|||||
Proceeds from long-term borrowings
|
30.8
|
-
|
||||||
Payments of long-term borrowings
|
(1.6
|
)
|
(1.6
|
)
|
||||
Net change in short-term borrowings
|
(39.0
|
)
|
-
|
|||||
Proceeds from policyholder deposits
|
16.4
|
8.2
|
||||||
Surrenders of policyholder deposits
|
(8.2
|
)
|
(11.4
|
)
|
||||
Repurchase and retirement of common stock
|
(14.9
|
)
|
-
|
|||||
Other
|
33.8
|
12.4
|
||||||
Net increase in cash and cash equivalents
|
$
|
31.2
|
$
|
48.7
|
Item 3. |
Quantitative and Qualitative Disclosures about Market Risk
|
Item 4. |
Controls and Procedures
|
Item 1. |
Legal Proceedings
|
Item 1A. |
Risk Factors
|
Item 2. |
Unregistered Sales of Equity Securities and Use of Proceeds
|
(Dollar amounts in millions, except per share data)
|
Total Number
of Shares
Purchased
(1)
|
Average
Price
Paid per
Share
|
Total Number of
Shares
Purchased as
Part of Publicly
Announced
Programs (1)
|
Approximate
Dollar Value of
Shares that May
Yet Be Purchased
Under the
Programs
|
||||||||||||
Apri 1, 2020 to April 30, 2020
|
197,739
|
$
|
15.15
|
197,739
|
$
|
3.0
|
||||||||||
May 1, 2020 to May 31, 2020
|
177,634
|
16.87
|
177,634
|
-
|
||||||||||||
June 1, 2020 to June 30, 2020
|
-
|
-
|
-
|
-
|
Item 3. |
Defaults Upon Senior Securities
|
Item 4. |
Mine Safety Disclosures
|
Item 5. |
Other Information
|
Item 6. |
Exhibits
|
Exhibits
|
Description
|
|
|
Amendment to the contract between Administracion de Seguros de Salud de Puerto Rico (ASES) and Triple-S Salud, Inc., to administer the Provision of Physical & Behavioral Health Services under the Government Health Plan dated as of May 1, 2020.
|
|
Amendment to the contract between Administracion de Seguros de Salud de Puerto Rico (ASES) and Triple-S Salud, Inc., to administer the Provision of Physical & Behavioral Health Services under the Government Health Plan dated as of June 29, 2020.
|
|
Amendment to the contract between Administracion de Seguros de Salud de Puerto Rico (ASES) and Triple-S Salud, Inc., to administer the Provision of Physical & Behavioral Health Services under the Government Health Plan dated as of July 31, 2020.
|
|
Statement re computation of per share earnings; an exhibit describing the computation of the earnings per share for the three and six months ended June 30, 2020 and 2019 has been omitted as the detail necessary to determine the computation of earnings per share can be clearly determined from the material contained in Part I of this Quarterly Report on Form 10-Q.
|
|
|
|
Certification of the President and Chief Executive Officer required by Rule 13a-14(a)/15d-14(a).
|
|
|
|
Certification of the Executive Vice President and Chief Financial Officer required by Rule 13a-14(a)/15d-14(a).
|
|
|
|
Certification of the President and Chief Executive Officer required pursuant to 18 U.S.C Section 1350.
|
|
|
|
Certification of the Executive Vice President and Chief Financial Officer required pursuant to 18 U.S.C Section 1350.
|
|
|
|
|
Triple-S Management Corporation
|
|
|
|
|
|
Registrant
|
|
|
|
|
|
|
|
Date:
|
August 6, 2020
|
|
By:
|
/s/ Roberto García-Rodríguez
|
|
|
|
|
|
Roberto García-Rodríguez
|
|
|
|
|
|
President and Chief Executive Officer
|
|
|
|
|
|
|
|
Date:
|
August 6, 2020
|
|
By:
|
/s/ Juan J. Román-Jiménez
|
|
|
|
|
|
Juan J. Román-Jiménez
|
|
|
|
|
|
Executive Vice President and Chief Financial Officer
|
I. |
AMENDMENTS
|
|
1. |
Section 2 shall be amended to add the following terms and its definition:
|
2.
|
Section 10.5.1.5 shall be amended and replaced in its entirety as follows:
|
10.5.1.5. |
With the exceptions noted below, the Contractor shall negotiate rates with Providers, and such rates shall be specified in the Provider Contract. Payment arrangements may take any
form allowed under Federal law and the laws of Puerto Rico, including Capitation payments, Fee-for-Service payment, and salary, if any, subject to Section 10.6 concerning permitted risk arrangements.
|
|
10.5.1.5.1 |
Claims submitted for professional services that are listed in the current Medicare Part B fee schedule, as established under Section 1848(b) of the Social Security Act, and as
applicable to the Puerto Rico locality, shall be reimbursed by the Contractor at not less than 70 percent (70%) of the payment that would apply to such services if they were furnished under Medicare Part B during the applicable fiscal year,
disregarding services that are paid through sub-capitated arrangements. Any claims subject to reimbursement in accordance with this Section 10.5.1.5.1 that have been reimbursed at less than 70 percent (70%) of the corresponding rates on the
Medicare Part B fee schedule shall be re-adjudicated for payment in compliance with this Section. The Contractor shall comply with all data collection and reporting requests from ASES, in the manner and frequency set forth by ASES, to
validate the Contractor’s compliance with this Section. ASES reserves the right to apply this section retroactively to January 1, 2020 if approved by CMS, the Puerto Rico Office of the Comptroller, and the Financial Oversight and
Management Board for Puerto Rico. Nothing in this Section requires the reduction of fees paid above the 70% of Medicare Part B fee schedule
|
|
10.5.1.5.2 |
Dental services as described in Section 7.6 shall be reimbursed in an amount no less than those amounts specified in Attachment 11-A to this Contract and shall not be subject to
the requirements set forth in Section 10.5.1.5.1.
|
|
3. |
Immediately following Section 10.6.1, a new Section 10.6.2 shall be inserted stating as follows:
|
|
10.6.2 |
The Contractor shall ensure that PMGs subject to a risk sharing arrangement with the Contractor receive an adjustment in budget, considering the difference between current fee for
service reimbursements for which the PMG is at risk and increases in reimbursement amounts necessary to meet new minimum reimbursement thresholds, as established in Section 10.5.1.5.1, unless a new financial arrangement is negotiated
between and agreed upon by the Contractor and the PMG.
|
|
4. |
Immediately following Section 22.1.1.1, a new Section 22.1.1.2 shall be inserted stating as follows:
|
|
22.1.1.2 |
The GHP (Vital) PMPM Payment rates included in Attachment 11 to this Contract, as amended, shall be effective to account for new requirements set forth in Section 10.5.1.5.1. ASES
will increase the per member per month (PMPM) capitation rates to MCOs to account for the additional costs incurred by the MCOs with respect to the minimum fee schedule, as of the effective date of the Amendment. If Section 10.5.1.5.1 is
applied retroactively to January 1, 2020, Attachment 11 shall be further amended to the extent necessary to accommodate additional impacts caused by such retroactivity to current PMPM Payment rates.
|
5.
|
Attachment 11 of the Contract, as amended, shall be replaced in its entirety by a new Attachment 11 as set forth in Exhibit A to this
Amendment. Attachment 11-A remains unchanged.
|
II. |
RATIFICATION
|
III. |
EFFECT; CMS APPROVAL
|
|
(1) |
Notwithstanding the foregoing, because Updated PMPM Payment Rates are subject to CMS and FOMB approval, ASES shall continue to pay Contractor at the PMPM Payment Rates that existed
prior to the Amendment Effective Date until such time as the Updated PMPM Payment Rates have been approved by CMS and FOMB;
|
|
(2) |
Within thirty (30) calendar days following CMS and FOMB approval of Updated PMPM Payment Rates, the parties shall begin to reconcile any difference in (i) PMPM Payments made by
ASES to Contractor after the Amendment Effective Date or January 1, 2020, as applicable, and (ii) Updated PMPM Payment Rates.
|
|
(3) |
The Contractor’s obligation as contemplated in Section 10.6.2 shall be effective after (i) approval from CMS and FOMB is granted; (ii) the parties reconcile any difference in PMPM
as of the Amendment Effective Date; and (iii) the reconciled increase in PMPM capitation rates are paid to the Contractor.
|
IV. |
AMENDMENT EFFECTIVE DATE
|
V. |
ENTIRE AGREEMENT
|
/s/ Jorge E. Galva Rodríguez
|
5/1/2020
|
Jorge E, Galva Rodríguez, JD, MHA
|
Date
|
/s/ Madeline Hernández Urquiza
|
5/1/2020
|
Madeline Hernández Urquiza
|
Date
|
Administracion de Seguros de Salud
May 1, 2020 to June 30, 2020
PSG (Vital) PMPM Premium Rates
|
||||
Rate Cell
|
PMPM Premium Rate
|
|||
Medicaid Pulmonary
|
$
|
229.84
|
||
Medicaid Diabetes or Low Cardio
|
$
|
364.98
|
||
Medicaid High Cardio
|
$
|
793.47
|
||
Medicaid Renal
|
$
|
1,616.11
|
||
Medicaid Cancer
|
$
|
1,921.36
|
||
Medicaid Male 45+
|
$
|
135.06
|
||
Medicaid Male 19-44
|
$
|
97.06
|
||
Medicaid Male 14-18
|
$
|
82.79
|
||
Medicaid Female 45+
|
$
|
178.62
|
||
Medicaid Female 19-44
|
$
|
128.15
|
||
Medicaid Female 14-18
|
$
|
96.70
|
||
Medicaid Age 7-13
|
$
|
84.79
|
||
Medicaid Age 1-6
|
$
|
96.67
|
||
Medicaid Under 1
|
$
|
258.32
|
||
Commonwealth Pulmonary
|
$
|
161.42
|
||
Commonwealth Diabetes or Low Cardio
|
$
|
198.81
|
||
Commonwealth High Cardio
|
$
|
434.65
|
||
Commonwealth Renal
|
$
|
663.54
|
||
Commonwealth Cancer
|
$
|
1,408.29
|
||
Commonwealth Male 45+
|
$
|
77.36
|
||
Commonwealth Male 19-44
|
$
|
54.52
|
||
Commonwealth Male 14-18
|
$
|
50.87
|
||
Commonwealth Female 45+
|
$
|
108.29
|
||
Commonwealth Female 19-44
|
$
|
92.38
|
||
Commonwealth Female 14-18
|
$
|
62.60
|
||
Commonwealth Age 7-13
|
$
|
67.54
|
||
Commonwealth Age 1-6
|
$
|
81.48
|
||
Commonwealth Under 1
|
$
|
275.77
|
||
CHIP Pulmonary
|
$
|
205.45
|
||
CHIP Diabetes
|
$
|
553.29
|
||
CHIP Age 7-13
|
$
|
76.17
|
||
CHIP Age 14+
|
$
|
70.28
|
||
CHIP Age 1-6
|
$
|
100.67
|
||
CHIP Under 1
|
$
|
269.43
|
||
Dual Eligible Part A and B
|
$
|
829.44
|
||
Dual Eligible Part A Only
|
$
|
353.51
|
||
Maternity Delivery Kick Payment
|
$
|
4,907.38
|
I.
|
AMENDMENTS
|
1.
|
Section 21.4.1 shall be amended as follows:
|
21.4.1 |
Notwithstanding anything to the contrary in this Agreement, because the parties have not completed the revision of the PMPM Payments by the expiration of the
current rating period which ends on June 30, 2020 (the “Expired Rating Period”) such that the new rating period must commence without updated PMPM
Payments, then the following shall occur:
|
(a) |
ASES shall continue to pay Contractors at the PMPM Payment rates that existed during the Expired Rating Period;
|
|
(b) |
As soon as practicable, but in no event more than thirty (30) days following the expiration of the Expired Rating Period, the parties shall complete in good faith
the review of updated PMPM Payments (the “Updated PMPM Payments”).
|
|
(c) |
Following agreement upon Updated PMPM Payments, the parties shall execute an amendment to Attachment 11 of the Contract setting forth the Updated PMPM Payments.
Such amendment and the Updated PMPM Payments shall be effective as of July 1st, 2020 as if the Updated PMPM Payments had been agreed upon at the expiration of the Expired Rating Period, provided that,
|
|
(1) |
Notwithstanding the foregoing, because Updated PMPM Payment rates are subject to CMS and FOMB approval, ASES will continue to pay Contractors at the PMPM Payment
rates that existed during the Expired Rating Period until such time as CMS and the FOMB have approved the Updated PMPM Payments, and;
|
|
(2) |
within thirty (30) calendar days following CMS’ and the FOMB’s approval of Updated PMPM Payment rates, the Parties shall begin to reconcile any difference between
(i) PMPM Payments that ASES made to Contractors after the Expired Rating Period and (ii) Updated PMPM Payment rates.
|
II.
|
RATIFICATION
|
III.
|
EFFECT; CMS APPROVAL
|
IV.
|
AMENDMENT EFFECTIVE DATE
|
V.
|
ENTIRE AGREEMENT
|
_/s/ Jorge E. Galva Rodríguez
|
6/29/2020
|
Jorge E. Galva Rodríguez, JD, MHA
|
Date
|
/s/ Madeline Hernández Urquiza
|
6/29/2020
|
Ms. Madeline Hernández Urquiza, President
|
Date
|
I. |
AMENDMENTS
|
|
1. |
Section 21.4.1 shall be amended as follows:
|
|
21.4.1 |
Notwithstanding anything to the contrary in this Contract, because the Parties have not completed the revision of the PMPM Payments by the expiration of the current
rating period which ended on June 30, 2020 (the “Expired Rating Period”) such that the new rating period must commence without revised PMPM Payments, then the following shall occur:
|
|
21.4.1.1 |
ASES shall continue to pay Contractors at the PMPM Payment rates that existed during the Expired Rating Period;
|
|
21.4.1.2 |
As soon as practicable, but in no event more than sixty (60) days following the expiration of the Expired Rating Period, or sooner if the revised PMPM Payments
(“Updated PMPM Payments”) become available, the Parties shall complete in good faith the review of the Updated PMPM Payments.
|
|
21.4.1.3 |
Following agreement upon the Updated PMPM Payments, the Parties shall execute an amendment to Attachment 11 of the Contract setting forth the Updated PMPM Payments.
Such amendment and the Updated PMPM Payments shall be effective as of July 1st, 2020 as if the Updated PMPM Payments had been agreed upon at the expiration of the Expired Rating Period, provided that,
|
|
21.4.1.3.1 |
Notwithstanding the foregoing, because Updated PMPM Payments are subject to CMS and the Financial Oversight and Management Board (“FOMB”) approval, ASES will
continue to pay Contractors at the PMPM Payment rates that existed during the Expired Rating Period until such time as CMS and the FOMB have approved the Updated PMPM Payments, and;
|
|
21.4.1.3.2 |
Within thirty (30) calendar days following CMS’s and the FOMB’s approval of the Updated PMPM Payments, the Parties shall begin to reconcile any difference between
(i) PMPM Payments that ASES made to Contractors after the Expired Rating Period and (ii) Updated PMPM Payments.
|
II. |
RATIFICATION
|
III. |
EFFECT; CMS APPROVAL
|
IV. |
AMENDMENT EFFECTIVE DATE
|
V. |
ENTIRE AGREEMENT
|
_/s/ Jorge E. Galva Rodríguez
|
7/31/2020
|
Name: Jorge E, Galva Rodríguez, JD, MHA
|
Date
|
/s/ Madeline Hernández Urquiza
|
7/31/2020
|
Ms. Madeline Hernández Urquiza, President
|
Date
|
1. |
I have reviewed this quarterly report on Form 10-Q of Triple-S Management Corporation;
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;
|
4. |
The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting
(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
|
a. |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
b. |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
c. |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by
this report based on such evaluation; and
|
|
d. |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially
affect, the registrant’s internal control over financial reporting; and
|
5. |
The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of
directors (or persons performing the equivalent functions):
|
|
a. |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and
report financial information; and
|
|
b. |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
August 6, 2020
|
|
By:
|
/s/ Roberto García-Rodríguez
|
|
|
|
|
|
Roberto García-Rodríguez
|
|
|
|
|
|
President and Chief Executive Officer
|
1. |
I have reviewed this quarterly report on Form 10-Q of Triple-S Management Corporation;
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not
misleading with respect to the period covered by this report;
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and
for, the periods presented in this report;
|
4. |
The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting
(as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
|
|
a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated
subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
|
|
b) |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and
the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
|
|
c) |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by
this report based on such evaluation; and
|
|
d) |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially
affect, the registrant’s internal control over financial reporting; and
|
5. |
The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of
directors (or persons performing the equivalent functions):
|
|
a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and
report financial information; and
|
|
b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
|
Date:
|
August 6, 2020
|
|
By:
|
/s/ Juan J. Román-Jiménez
|
|
|
|
|
|
Juan J. Román-Jiménez
|
|
|
|
|
|
Executive Vice President and Chief Financial Officer
|
|
a) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
b) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date:
|
August 6, 2020
|
|
By:
|
/s/ Roberto García-Rodríguez
|
|
|
|
|
|
Roberto García-Rodríguez
|
|
|
|
|
|
President and Chief Executive Officer
|
|
a) |
The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|
|
b) |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|
Date:
|
August 6, 2020
|
|
By:
|
/s/ Juan J. Román-Jiménez
|
|
|
|
|
|
Juan J. Román-Jiménez
|
|
|
|
|
|
Executive Vice President and Chief Financial Officer
|